HepG2 Transfection Kits

* This product is for research use only. Not intended for use in the treatment or diagnosis of disease.

Catalog Product Name Inquiry
BT-000013 HepG2 Transfection Reagent Inquiry
BT-000014 HepG2 CRISPR Transfection Reagent Inquiry

BOC Sciences' HepG2 Transfection Kit is optimized in HepG2 cells and enables a high-efficiency transfer of siRNA, miRNA or plasmid DNA into the cells.

Introduction of HepG2 cells

HepG2 cells were derived from liver cancer tissue in a 15-year-old white man. The cells secrete a variety of plasma proteins: albumin, α2-Macroglobulin, plasminogen, transferrin, etc., and express 3-hydroxy-3-methylglutarate coenzyme A reductase and hepatic triglyceride lipase. In the presence of gramoxone, the expression of catalase mRNA was increased, and the expression of ApoA-I mRNA was decreased. The cells can be cultured in large volumes, negative for hepatitis B surface antigen, resistant to G418, and stimulatory to human growth hormone. Human hepatoma cell HEPG2 is the most common cancer in the world and the third leading cause of cancer death. HepG2 does not contain hepatitis B virus (HBV) and hepatitis C virus (HCV), so HepG2 is a commonly used cell line model to study HBV and HCV.

Hela Transfection Kits

ProductsCell TypesDetails
HepG2 Transfection ReagentHepG2 cell lineBOC Sciences HepG2 Transfection Reagent is a unique formulation based on cationic liposomes of non-animal origin. It is designed to transfect HepG2 cell line and is ideal for in vitro delivery of DNA and RNA.
HepG2 CRISPR Transfection ReagentHepG2 cell lineBOC Sciences provides specially optimized HepG2 CRISPR transfection reagent, which is specially used to efficiently deliver the CRISPR/Cas9 system in the HepG2 cells to achieve efficient gene editing.

Highlights

  • Low cytotoxicity, using optimized cationic lipid formulations
  • Repeatable and reliable results
  • Serum compatible

Related Sections: